BioSante Pharmaceuticals Reports Second Quarter Financial Results and ...

News | 02 August 2012

BioSante's corporate strategy is the development of high value medically-needed pharmaceutical products, as well as seeking to implement strategic alternatives with respect to its products and its company, including licenses, business collaborations ...

Click on the link to read the full article at PharmiWeb.com (press release)
(This link will open in a new window)